...
首页> 外文期刊>cell regeneration >Human liver organoid: modeling liver steatosis and beyond
【24h】

Human liver organoid: modeling liver steatosis and beyond

机译:

获取原文
           

摘要

© 2023, The Author(s).Steatosis, as the early stage of nonalcoholic fatty acid disease (NAFLD), would progress into nonalcoholic steatohepatitis (NASH) and liver failure without intervention. Despite the development of animal models, there is still a lack of the human-relevant platform for steatosis modeling and drug target discovery. Hendriks et al., reporting in Nature Biotechnology, leveraged human fetal liver organoids to recapitulate steatosis by introducing nutritional and genetic triggers. Using these engineered liver organoid-derived steatosis models, they screened drugs that alleviate steatosis, and mined common mechanism of effective compounds. Further, inspired by the results of drug screening, the arrayed CRISPR-LOF screening targeting 35 lipid metabolism genes was performed, and FADS2 was identified as a critical regulator of steatosis.

著录项

  • 来源
    《cell regeneration》 |2023年第1期|共页
  • 作者

    Wei J.; Zhang W.; Zhao B.;

  • 作者单位

    State Key Laboratory of Genetic Engineering School of Life Sciences Zhongshan Hospital Fudan University;

    Greater Bay Area Institute of Precision Medicine (Guangzhou) Fudan University;

    Institute of Organoid Technology bioGenous Biotechnology Inc;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 英语
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号